Metastatic renal cell carcinoma
RecruitingStudy Comparing Gallium (68Ga) Gozetotide and Zirconium (89Zr) Girentuximab PET Scans for Detecting Tumors in Patients with Metastatic Renal Cell Carcinoma
Study Comparing Gallium (68Ga) Gozetotide and Zirconium (89Zr) Girentuximab PET Scans for Detecting Tumors in Patients with Metastatic Renal Cell Carcinoma
- Disease:Metastatic renal cell carcinoma
- Substances:GozetotideGallium (68GA) gozetotide+1
The Netherlands- Participants:18–64 years · 65+ years
- Substances:Gozetotide




